BROADCASTS.com

Many pharmaceutical companies are getting out of Alzheimer\u2019s research because they aren\u2019t finding that \u201csilver bullet\u201d treatment to cure the disease. However, perhaps we should instead be looking for the \u201csilver buckshot\u201d treatment, because it is only by addressing many smaller areas of concern that you effectively reduce your risk for Alzheimer\u2019s Disease. In the second episode of a series with Dr. David Perlmutter, Dr. Daniel Amen and Tana Amen discuss some of these \u201csilver buckshot\u201d elements, such as exercise and monitoring your glycemic load.